FDA Inspection 1068254 — Glaukos Corporation
The FDA completed an inspection of Glaukos Corporation on Aug 3, 2018 in San Clemente, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 3, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- San Clemente, CA (United States)
Additional details
Sponsor, Contract Research Organization